SEC 13F Intelligence

Propel Bio Management, LLC / TRVI

Propel Bio Management, LLC’s Trevi Therapeutics Inc Position

Does Propel Bio Management, LLC own Trevi Therapeutics Inc (TRVI)? Yes — 223.8K shares worth $3M (+1.67% of its 13F portfolio) as of Q1 2026, down from 260.0K shares the prior filed quarter.

Position Value
$3M
Q1 2026
Shares
223.8K
% of Portfolio
+1.67%
Quarters Held
3
currently held

Position History TRVI

Reported value by quarter
Q1 ’24: $897,000Q1 ’24Q2 ’24: $774,800Q2 ’24Q1 ’26: $3MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026223.8K$3M+1.67%
Q2 2024260.0K$774,800+0.50%
Q1 2024260.0K$897,000+0.52%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of TRVI.